CVAC up 10% > CureVac shares are trading higher after the company announced it is in advanced discussions with the European Commission to supply up to 405 million doses of potential mRNA-based COVID-19 vaccines.
OPGN up 46% > OpGen Announces CE-IVD Marking And Commercial Launch In Europe Of Its Own Developed Molecular Diagnostic Sars-CoV-2 Kit With PULB For Detection Of The Virus Causing COVID-19